GRI Bio Announces Partnership with the Respiratory Translational Research Collaboration to Advance Leading NKT Regulation Technology Targeting Earlier in the Inflammatory Cascade to Modulate Disease Progression
17 oct. 2023 08h35 HE
|
GRI Bio, Inc.
UK consortia brings together internationally recognized investigators in the UK's leading centers of excellence to carry out experimental and early phase research Translational work to be...
GRI Bio Enters into Asset Purchase Agreement with Aardvark Therapeutics, Inc. for the Sale of Legacy Asset, ADAIR
23 août 2023 09h00 HE
|
GRI Bio, Inc.
Aardvark to acquire global development and commercialization rights to ADAIR and all intellectual property outside of Europe and licensor rights for the EU Aardvark to leverage ADAIR formulation...
GRI Bio (NASDAQ: GRI) to Present at the Virtual Investor – The GRI Opportunity Spotlight Event
24 juil. 2023 09h00 HE
|
GRI Bio, Inc.
- Live moderated webcast with members of the GRI Bio management team on Thursday, July 27th at 1:00 PM ET LA JOLLA, CA, July 24, 2023 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio”...
NKT tildelt rekordordrer til verdens første 525 kV XLPE HVDC kabelprojekter til havvind
03 mars 2023 02h15 HE
|
Nkt A/S
Selskabsmeddelelse 3. marts 2023 Meddelelse nr. 7NKT tildelt rekordordrer til verdens første 525 kV XLPE HVDC kabelprojekter til havvind NKT er blevet tildelt tre turnkey kabelprojekter til...
NKT awarded record orders for world’s first 525 kV XLPE HVDC submarine cable projects for offshore wind
03 mars 2023 02h15 HE
|
Nkt A/S
Company Announcement 3 March 2023 Announcement No. 7 NKT awarded record orders for world’s first 525 kV XLPE HVDC submarine cable projects for offshore wind NKT has been awarded...
Vallon Pharmaceuticals Reports Fiscal Year 2022 Financial Results
24 févr. 2023 07h30 HE
|
Vallon Pharmaceuticals Inc.
PHILADELPHIA, PA, Feb. 24, 2023 (GLOBE NEWSWIRE) -- Vallon Pharmaceuticals, Inc. (NASDAQ: VLON), (“Vallon” or the “Company”), today reported its financial results for the fiscal year ended December...
Vallon Pharmaceuticals and GRI Bio to Present at the Virtual Investor 2023 Companies to Watch Event
11 janv. 2023 08h45 HE
|
Vallon Pharmaceuticals Inc.
Live video webcast on Tuesday, January 17, 2023 at 1:00 PM ET PHILADELPHIA, PA and LA JOLLA, CA, Jan. 11, 2023 (GLOBE NEWSWIRE) -- Vallon Pharmaceuticals, Inc. (NASDAQ: VLON), (“Vallon” or the...
NKT bekræfter ordre på Dogger Bank havvindmølleparkerne Creyke Beck A/B
19 nov. 2019 07h21 HE
|
Nkt A/S
Selskabsmeddelelse 19. november 2019 Meddelelse nr. 14 NKT bekræfter ordre på Dogger Bank havvindmølleparkerne Creyke Beck A/BSom informeret i Selskabsmeddelelse nr. 11 af 20. september 2019, har...
NKT confirms order for Dogger Bank offshore Wind Farms Creyke Beck A/B
19 nov. 2019 07h21 HE
|
Nkt A/S
Company Announcement 19 November 2019 Announcement No. 14 NKT confirms order for Dogger Bank offshore Wind Farms Creyke Beck A/BAs informed in Company Announcement no. 11 of 20 September 2019, NKT...
NKT bekræfter turnkey ordre på havvindmølleprojektet Moray East
02 nov. 2018 14h23 HE
|
Nkt A/S
Selskabsmeddelelse 2. november 2018 Meddelelse nr. 15 NKT bekræfter turnkey ordre på havvindmølleprojektet Moray East Som informeret i selskabsmeddelelse nr. 30 af 13. november 2017, havde NKT...